Species : |
Human |
Source : |
Human |
Tag : |
Non |
Description : |
EMAP-II is a tumor derived cytokine that exerts a wide range of activities on endothelial cells, monocytes and neutrophils. EMAP-II inhibits endothelial cell proliferation, vasculogenesis, neovessel formation, and can induce apoptosis. It is also chemotactic towards neutrophils and monocytes and induces myeloperoxidase activity from neutrophils. Of clinical importance, EMAP-II inhibits angiogenesis of vascular beds and suppresses the growth of primary and secondary tumors without affecting normal tissues. Mature EMAP-II is an 18.3 kDa protein, which is synthesized as the C-terminal portion of a biologically inactive precursor protein containing a propeptide of 146 amino acid residues. |
Form : |
Supplied as a lyophilized powder. |
Purity : |
>98% pure by SDS PAGE and HPLC |
Sequence : |
Region of EMAP II protein corresponding to amino acids SKPIDVSRLD LRIGCIITAR KHPDADSLYV EEVDVGEIAP RTVVSGLVNH VPLEQMQNRM VILLCNLKPA KMRGVLSQAM VMCASSPEKI EILAPPNGSV PGDRITFDAF PGEPDKELNP KKKIWEQIQP DLHTNDECVA TYKGVPFEVK GKGVCRAQTM SNSGIK. |
Molecular Mass : |
18.3 kDa |
Applications : |
Numerous applications are possible with this product and should be tested by the end user under their own laboratory conditions |
Endotoxin Levels : |
Endotoxin level is less than 0.1 ng per ug (1 EU/ug). |
Bioactivity : |
Determined by the apoptotic effect on MCF-7 cells using a concentration of 20-40 ng/ml. |
Storage : |
Store at 4 deg C for short term storage (1/2 weeks). Aliquot and store at -20 deg C or - 70 deg C for long term storage. Avoid repeated freeze/thaw cycles. |